EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...

The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...

More than a dozen bacterial species that live in people's mouths have been linked to a...

Content from other channels on our network

SA project uses Cement Australia's low-carbon tech

Data centres working to use water responsibly

Orica cuts particle emissions from Kooragang Island site by around 95%

CSIRO's new facility for printed flexible solar techology

Driving change: how electric vehicles are fuelling Australia's sustainable businesses

Nestlé develops algorithm to uncover dogs' bio age

AFGC's response to the ACCC's supermarket inquiry

Grant to advance probiotic microencapsulation tech

Pacific Automation: Automation Components and Solutions for Australia's Food Processing Industry

What's New in Palletising

Burnet, Atomo to jointly develop active syphilis self-test

My Health Record: ADHA seeks industry input on support, maintenance

Monash, Optiscan partner to develop AI-powered endoscopes

Review proposes major health system changes

Private Health CEO Forum to tackle financial viability issues